Semrush Holdings, Inc. (SEMR) Q4 2024 Earnings Call Transcript — Neutral

SEMR   Seeking Alpha — February 27, 2025

Semrush Holdings, Inc. (NYSE:SEMR ) Q4 2024 Earnings Conference Call February 27, 2024 8:30 AM ET Company Participants Brinlea Johnson - IR Oleg Shchegolev - CEO Bill Wagner - Incoming CEO Eugene Levin - President Brian Mulroy - CFO Conference Call Participants Elizabeth Porter - Morgan Stanley Luke Horton - Northland Capital Markets Jackson Ader - KeyBanc Capital Markets Scott Berg - Needham Operator Good morning and thank you for attending to Semrush Holdings Fourth Quarter and Full Year 2024 Results Conference Call. My name is Brica, and I will be your moderator today's call.

image for news Semrush Holdings, Inc. (SEMR) Q4 2024 Earnings Call Transcript

Can Nvidia's bull run continue? — Neutral

NVDA   CNBC Television — February 27, 2025

The Investment Committee debate Nvidia's earnings report and how to trade the name from here.

image for news Can Nvidia's bull run continue?

Cmb.Tech NV (CMBT) Q4 2024 Earnings Call Transcript — Neutral

CMBT   Seeking Alpha — February 27, 2025

Cmb.Tech NV (NYSE:CMBT ) Q4 2024 Earnings Conference Call February 27, 2024 8:00 AM ET Company Participants Alexander Saverys - CEO Ludovic Saverys - CFO Enya Derkinderen - Communications Coordinator Conference Call Participants Alexander Saverys Okay. Good afternoon, everyone, and thank you for joining the CMB.TECH Earnings Call for the Fourth Quarter of 2024.

image for news Cmb.Tech NV (CMBT) Q4 2024 Earnings Call Transcript

Nvidia stock receives a downgrade despite strong earnings — Negative

NVDA   Invezz — February 27, 2025

Nvidia Corp (NASDAQ: NVDA) came in well ahead of Street estimates for its fourth quarter last night but one Wall Street analyst continues to see some challenges for the AI darling ahead.

image for news Nvidia stock receives a downgrade despite strong earnings

GoodRx Holdings Inc. GDRX reported fourth-quarter revenue of $198.6 million, up slightly by 1% year over year, missing the management guidance of around $200 million and consensus of $199.75 million.

image for news GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales

4 Silver Mining Stocks to Watch on Solid Industry Trends — Positive

AG  BVN  FNLPF  HL   Zacks Investment Research — February 27, 2025

The Zacks Mining - Silver industry's prospects look upbeat on rising silver prices and strong demand. Stocks like FNLPF, HL, BVN and AG are worth keeping tabs on.

image for news 4 Silver Mining Stocks to Watch on Solid Industry Trends

BRK.B Stock Expensive: Should You Buy It Post Solid Q4 Show? — Positive

BRK-A  BRK-B   Zacks Investment Research — February 27, 2025

Investors who already own Berkshire shares should hold it, while others can wait for some more time before investing.

image for news BRK.B Stock Expensive: Should You Buy It Post Solid Q4 Show?

Talos Energy, Inc. (TALO) Q4 2024 Earnings Call Transcript — Neutral

TALO   Seeking Alpha — February 27, 2025

Talos Energy, Inc. (NYSE:TALO ) Q4 2024 Earnings Conference Call February 27, 2025 10:00 AM ET Company Participants Clay Jeansonne - Head, IR Bill Moss - Interim CEO, Co-President & General Counsel Sergio Maiworm - Interim Co-President & CFO John Spath - Interim Co-President & Head, Operations Conference Call Participants Nate Pendleton - Texas Capital Leo Mariani - Roth Tim Rezvan - KeyBanc Capital Markets. Michael Scialla - Stephens Jeff Robertson - Water Tower Research Michael Furrow - Pickering Energy Partners Paul Diamond - Citi Arun Jayaram - J.P.

image for news Talos Energy, Inc. (TALO) Q4 2024 Earnings Call Transcript

NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Soho House & Co. Inc. (NYSE:SHCO), the board of directors, and the controlling stockholder for potential breaches of fiduciary duty. If you are a holder of Soho House, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/soho-house-co-inc.

image for news SHCO BREAKING NEWS: BFA Law Announces an Investigation into Soho House & Co. for Breaches of Fiduciary Duties; Current Shareholders are Urged to Contact the Firm

This Battered Bill Ackman Stock Could Be on the Cusp of a Huge Turnaround — Positive

NKE   24/7 Wall Street — February 27, 2025

Pershing Square Capital Holdings' Bill Ackman is perhaps best known for concentrated investments in a handful of “wonderful,” easy-to-understand businesses flush with free cash flow.

image for news This Battered Bill Ackman Stock Could Be on the Cusp of a Huge Turnaround

JP Morgan analyst Pinjalim Bora maintained an Underweight rating on C3.ai, Inc AI with a price target of $27, down from $28.

image for news C3.ai Sees Stronger Revenue But Analyst Concerned Over Profitability And Scale

Target Teams With Warby Parker for in-Store Eyewear Shopping — Positive

TGT   PYMNTS — February 27, 2025

Target is opening a series of “shop-in-shops” in partnership with eyewear maker Warby Parker. The collaboration, announced Thursday (Feb. 27), will bring five “Warby Parker at Target” outposts to stores around the country, and comes at a time when Target and other retailers are dealing with consumer pullbacks.

image for news Target Teams With Warby Parker for in-Store Eyewear Shopping

Fox, Disney and Warner Bros. Discovery disbanded their efforts to launch Venu, a joint sports streaming service.

image for news Venu is done. Here's how Fox, Disney and WBD plan to go it alone in sports streaming

BERKELEY HEIGHTS, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicines, today announced a change in control and leadership on February 26, 2025.

image for news Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

OneMain: Hold Now, Fairly Valued Yet Bearish — Negative

OMF   Seeking Alpha — February 27, 2025

OneMain Holdings, Inc. shows modest revenue growth and stable margins despite higher credit loss provisions and increased operating expenses. The company enjoys robust loan growth and improved credit trends, but delinquencies warrant caution. OMF's stock appears expensive relative to its valuation metrics, with technical indicators suggesting potential downside risks.

image for news OneMain: Hold Now, Fairly Valued Yet Bearish

Trade Tracker: Rob Sechan buys Arista Networks — Positive

ANET   CNBC Television — February 27, 2025

Rob Sechan, CEO of NewEdge Wealth, joins CNBC's "Halftime Report" to explain why he's buying Arista Networks.

image for news Trade Tracker: Rob Sechan buys Arista Networks

Trade Tracker: Bryn Talkington buys more Uber — Positive

UBER   CNBC Television — February 27, 2025

Bryn Talkington, Managing Partner of Requisite Capital Management, joins CNBC's "Halftime Report" to explain why she's buying more Uber.

image for news Trade Tracker: Bryn Talkington buys more Uber

Essential Utilities, Inc. (WTRG) Q4 2024 Earnings Call Transcript — Neutral

WTRG   Seeking Alpha — February 27, 2025

Essential Utilities, Inc. (NYSE:WTRG ) Q4 2024 Earnings Conference Call February 27, 2025 11:00 AM ET Company Participants Dan Schuller - Executive Vice President & Chief Financial Officer Chris Franklin - Chairman & Chief Executive Officer Conference Call Participants Ryan Connors - North Coast Research Durgesh Chopra - Evercore ISI Travis Miller - Morningstar Operator Thank you for standing by. My name is Ellie, and I will be your conference operator for today.

image for news Essential Utilities, Inc. (WTRG) Q4 2024 Earnings Call Transcript

Snowflake Enjoys Avalanche of Growth and Profitability — Positive

SNOW   24/7 Wall Street — February 27, 2025

Snowflake ( NASDAQ:SNOW ) is proving the turnaround strategy is working.

image for news Snowflake Enjoys Avalanche of Growth and Profitability

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. (NASDAQ: EPIX) between December 12, 2023 and October 31, 2024, inclusive (the “Class Period”), of the important March 25, 2025 lead plaintiff deadline.

image for news ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX